INCREASED ACTIVITY AND SENSITIVITY OF MITOCHONDRIAL RESPIRATORY ENZYMES TO TUMOR-NECROSIS-FACTOR ALPHA-MEDIATED INHIBITION IS ASSOCIATED WITH INCREASED CYTOTOXICITY IN DRUG-RESISTANT LEUKEMIC-CELL LINES
L. Jia et al., INCREASED ACTIVITY AND SENSITIVITY OF MITOCHONDRIAL RESPIRATORY ENZYMES TO TUMOR-NECROSIS-FACTOR ALPHA-MEDIATED INHIBITION IS ASSOCIATED WITH INCREASED CYTOTOXICITY IN DRUG-RESISTANT LEUKEMIC-CELL LINES, Blood, 87(6), 1996, pp. 2401-2410
The drug-resistant leukemic cell lines, CEM/VLB(100) and K/DAU(600), a
re more sensitive to tumor necrosis factor alpha (TNF alpha)-mediated
cytotoxicity compared with their parental cell lines, CCRF-CEM and K56
2 cl.6. Drug-resistant leukemic cell lines have more active mitochondr
ial function, which is associated with a greater susceptibility to TNF
alpha-induced respiratory inhibition. TNF alpha blocked electron tran
sfer at three sites, NADH dehydrogenase (complex I), succinate dehydro
genase (complex II), and cytochrome c oxidase (complex IV). Respirator
y rate and electron transport chain enzyme activities were significant
ly inhibited in the drug-resistant, TNF-sensitive cell lines. Respirat
ory inhibition preceded cell death by at least 5 to 8 hours. The respi
ratory failure was not compensated for by appropriate up-regulation of
the glycolytic pathway. Increasing mitochondrial respiratory rate and
enzyme activities by long-term culture with 2 mmol/L adenosine 5'-dip
hosphate (ADP) and Pi sensitized both drug-sensitive and drug-resistan
t cells to TNF alpha-induced cytolysis. Intramitochondrial free radica
ls generated by paraquat only had a limited and delayed effect on resp
iratory inhibition and cytolysis in comparison with the effect of TNF
alpha. We conclude that TNF alpha-induced cytotoxicity in leukemic cel
ls is, at least in part, mediated by inhibition of mitochondrial respi
ration. Free radical generation by TNF alpha may not directly lead to
the observed inhibition of the mitochondrial electron transport and ot
her mechanisms must be involved. (C) 1996 by The American Society of H
ematology.